MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202541133987 A) filed by Dr. R. Jothi Chitra; Dr. B. Sridevi; Dr. M. Sivarathinabala; Mr. K. Ragupathi; Mr. Dharshan G; Mr. Mohammed Hanifa M; and Mr. Sathish N, Chennai, Tamil Nadu, on Dec. 31, 2025, for 'mobile health app for chronic asthma monitoring and telemedicine using smart inhaler.'
Inventor(s) include Dr. R. Jothi Chitra; Dr. B. Sridevi; Dr. M. Sivarathinabala; Mr. K. Ragupathi; Mr. Dharshan G; Mr. Mohammed Hanifa M; and Mr. Sathish N.
The application for the patent was published on Jan. 9, under issue no. 02/2026.
According to the abstract released by the Intellectual Property India: "Asthma, a chronic respiratory disorder affecting millions globally, demands accurate medication delivery and continuous monitoring to ensure effective management. Conventional inhalers, while essential, often face challenges in usage accuracy due to poor patient technique, irregular monitoring, and lack of adherence. To address these issues, this project presents the design and development of a smart inhaler system integrated with a mobile health application aimed at enhancing medication efficiency and supporting remote healthcare. The proposed system includes a compact, retrofittable module that can be clipped onto traditional inhalers. It utilizes airflow sensors to detect parameters such as inhalation strength, duration, and timing. A microcontroller-based system processes these real-time inputs and triggers a servo motor mechanism to actuate the inhaler only when optimal inhalation conditions are detected. This automation ensures accurate drug delivery and minimizes medication wastage due to mistimed actuation. The smart inhaler is further enhanced with Bluetooth connectivity, enabling seamless communication with a mobile application. The app acts as an interface for users, providing real-time feedback, inhalation history, usage analytics, and reminder notifications to promote regular usage. Additionally, the collected data is stored and can be shared with healthcare professionals for remote monitoring and personalized treatment recommendations."
Disclaimer: Curated by HT Syndication.
